Novartis Issues Recall For Children’s Cold Syrups

On Thursday, January 31, 2013, Novartis issued a voluntary recall for several lots of its Triaminic and Theraflu syrups, citing potentially faulty child-resistant caps. The Consumer Product Safety Commission said there have been “12 reports of children unscrewing the locked caps," including four reports of product ingestion among children, one of which “required medical attention.” The recall covers 142 production lots of Triaminic syrups and 41 lots of Theraflu syrups. The affected lots were manufactured between May 2010 and December 2011 at the Lincoln, NE facility, which the company closed in 2011 after FDA inspectors found numerous quality-control problems. Novartis is instructing consumers, retail outlets and wholesalers to return the products for a full refund.